Esprit Scaffold Crosses Durability Hurdle in Below the Knee PAD
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — SAN FRANCISCO — Providing high durability, the Esprit resorbable drug-eluting scaffold (DRS) maintained superior results 3 years after initiation of the LIFE-BTK trial. For infrapopliteal artery disease causing chronic threat to the limbs…
